Head and Neck TumorsHead and Neck TumorsОпухоли головы и шеи2222-14682411-4634Publishing House ABV Press40510.17650/2222-1468-2019-9-2-53-65REVIEWОБЗОРНАЯ СТАТЬЯPrevalence, clinical significance and possible correction of taste and smell abnormalities in patients with oncological diseasesРаспространенность, клиническое значение и возможности коррекции нарушений обоняния и восприятия вкуса у пациентов с онкологическими заболеваниямиhttps://orcid.org/0000-0002-9181-7811GevorkovA. R.ГеворковА. Р.
Russian Federation

32nd Botkinsky Proezd, Moscow 125284

Артем Рубенович Геворков

125284 Москва, 2-й Боткинский пр., 3

dr.gevorkov@gmail.comhttps://orcid.org/0000-0003-1766-0059BoykoA. V.БойкоА. В.
Russian Federation

32nd Botkinsky Proezd, Moscow 125284

125284 Москва, 2-й Боткинский пр., 3

https://orcid.org/0000-0003-2613-4122VolkovaE. E.ВолковаЕ. Э.
Russian Federation

Block B, Riga Land, 26 km of Baltiya Road, Krasnogorsk District, Moscow Region 143421

143421 Московская область, Красногорский район, автодорога «Балтия», 26-й км, БЦ«Рига Лэнд», блок В

https://orcid.org/0000-0002-1683-0434ShashkovS. V.ШашковС. В.
Russian Federation

32nd Botkinsky Proezd, Moscow 125284

125284 Москва, 2-й Боткинский пр., 3

P.A. Hertzen Moscow Oncology Research Institute — branch of the National Medical Research Radiology Center of the Ministry of Health of RussiaМосковский научно-исследовательский онкологический институт им. П.А. Герцена — филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава РоссииNutricia AdvancedНутриция Эдванс, ООО020720199253650107201901072019Copyright ©; 2019, Gevorkov A.R., Boyko A.V., Volkova E.E., Shashkov S.V.Copyright ©; 2019, Геворков А.Р., Бойко А.В., Волкова Е.Э., Шашков С.В.2019Gevorkov A.R., Boyko A.V., Volkova E.E., Shashkov S.V.Геворков А.Р., Бойко А.В., Волкова Е.Э., Шашков С.В.https://creativecommons.org/licenses/by/4.0https://ogsh.abvpress.ru/jour/article/view/405

The article discusses main issues relating to abnormal taste and smell, which may an oncologist come across in the treatment practice. It also describes mechanisms of dysgeusia and disosmia development, as well as their relationship with nutritional deficiency. Authors review approaches to assess sensory disorders before treatment, at all the stages and after radiation therapy and chemotherapy. They present the world experience in managing patients with the abnormalities and their possible correction.

В статье обсуждаются основные вопросы, касающиеся нарушений восприятия вкуса и обоняния, с которыми может столкнуться онколог в своей практике. Описаны механизмы развития дисгевзии и дизосмии, а также их связь с нутритивной недостаточностью. Изложены подходы к оценке сенсорных нарушений до лечения, на всех его этапах и после завершения лучевой терапии и химиотерапии. Представлен мировой опыт ведения больных с подобными изменениями, рассмотрены возможности их коррекции.

oncological diseasessensory disorderdysgeusiadisosmiaradiation therapychemotherapylife qualityaccompanying therapynutritive insufficiencynutritive supportонкологические заболеваниясенсорные нарушениядисгевзиядизосмиялучевая терапияхимиотерапиякачество жизнисопроводительная терапиянутритивная недостаточностьнутритивная поддержкаBarrera R. Nutritional support in cancer patients. JPEN J Parenter Enteral Nutr 2002;26(5 Suppl):S63-71. DOI: 10.1177/014860710202600516.Bozzetti F., Gavazzi C., Miceli R. et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. JPEN J Parenter Enteral Nutr 2000;24(1):7-14. DOI: 10.1177/014860710002400107.Bozzetti F. Nutrition and gastrointestinal cancer. Curr Opin Clin Nutr Metab Care 2001;4(6):541-6.Mondello P., Mian M., Aloisi C. et al. Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options. Nutr Cancer 2015;67(1):12-26. DOI: 10.1080/01635581.2015.976318.Hebuterne X., Lemarie E., Michallet M. et al. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr 2014;38(2):196—204. DOI: 10.1177/0148607113502674.Yavuzsen T., Walsh D., Davis M.P. et al. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 2009;17(12):1531—41. DOI: 10.1007/s00520-009-0623-5.Hutton J.L., Baracos V.E., Wismer W.V. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 2007;33(2):156—65. DOI: 10.1016/j.jpainsymman.2006.07.017.Brisbois T.D., de Kock I.H., Watanabe S.M. et al. Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. J Pain Symptom Manage 2011;41(4):673—83. DOI: 10.1016/j.jpainsymman.2010.06.022.Bernhardson B.M., Tishelman C., Rutqvist L.E. Taste and smell changes in patients receiving cancer chemotherapy: distress, impact on daily life, and self-care strategies. Cancer Nurs 2009;32(1):45-54. DOI: 10.1097/01.NCC.0000343368.06247.74Brisbois T.D., Hutton J.L., Baracos V.E., Wismer W.V. Taste and smell abnormalities as an independent cause of failure of food intake in patients with advanced cancer -an argument for the application of sensory science. J Palliat Care 2006;22(2):111-4.Hong J.H., Omur-Ozbek P., Stanek B.T. et al. Taste and odor abnormalities in cancer patients. J Support Oncol 2009;7(2):58—65.Epstein J.B., Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol 2010;46(2):77-81. DOI: 10.1016/j.oraloncology.2009.11.008.Chaudhari N., Landin A.M., Roper S.D. A metabotropic glutamate receptor variant functions as a taste receptor. Nat Neurosci 2000;3(2):113—9. DOI: 10.1038/72053.Sugita M. Taste perception and coding in the periphery. Cell Mol Life Sci 2006;63(17):2000—15. DOI: 10.1007/s00018-006-6100-0.Rolls E.T. Brain mechanisms underlying flavour and appetite. Philos Trans R Soc Lond B Biol Sci 2006;361(1471):1123—36. DOI: 10.1098/rstb.2006.1852.Bernhardson B.M., Tishelman C., Rutqvist L.E. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 2008;16(3):275—83. DOI: 10.1007/s00520-007-0319-7.Duffy V., Fast K., Lucchina L., Bartoshuk L. Oral sensation and cancer. In: Principles and practice of palliative care and supportive oncology. Ed. by A. Berger, R. Portenoy, D. Weissman. Philadelphia: Lippincott Williams & Wilkins, 2002. Pp. 178-193.Kamath S., Booth P., Lad T.E. et al. Taste thresholds of patients with cancer of the esophagus. Cancer 1983;52(2):386—9.Langius J.A., Doornaert P., Spreeuwen-berg M.D. et al. Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer. Radiother Oncol 2010;97(1):80—5. DOI: 10.1016/j.radonc.2010.02.017.Matthews T.W., Lampe H.B., Dragosz K. Nutritional status in head and neck cancer patients. J Otolaryngol 1995;24(2):87—91.Unsal D., Mentes B., Akmansu M. et al. Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol 2006;29(2):183—8.Meyer F., Fortin A., Wang C.S. et al. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 2012;82(4):1454—62. DOI: 10.1016/j.ijrobp.2011.04.022.Capuano G., Grosso A., Gentile P.C. et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradio-therapy. Head Neck 2008;30(4):503-8. DOI: 10.1002/hed.20737.Langius J.A., van Dijk A.M., Doornaert P. et al. More than 10 % weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer 2013;65(1):76—83. DOI: 10.1080/01635581.2013.741749.Obukhova O.A., Kurmukov I.A., Kasiya Sh.R. Nutritional support in oncology. Oncoginekologiya = Gynecologic Oncology 2014;(1):34—45. (In Russ.).Обухова О.А., Курмуков ИА, Кашия Ш.Р. Питательная поддержка в онкологии. Онкогинекология 2014;(1):34—45.Mahmoud F.A., Aktas A., Walsh D., Hullihen B. A pilot study of taste changes among hospice in patients with advanced cancer. Am J Hosp Palliat Care 2011;28(7):487—92. DOI: 10.1177/1049909111402187.Gamper E.M., Zabernigg A., Wintner L.M. et al. Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review. J Pain Symptom Manage 2012;44(6):880—95. DOI: 10.1016/j.jpainsymman.2011.11.011.Murphy C., Quinonez C., Nordin S. Reliability and validity of electrogusto-metry and its application to young and elderly persons. Chem Senses 1995;20(5):499—503. DOI: 10.1093/chemse/20.5.499.Berling K., Knutsson J., Rosenblad A., von Unge M. Evaluation of electrogusto-metry and the filter paper disc method for taste assessment. Acta Otolaryngol 2011;131(5):488—93. DOI: 10.3109/00016489.2010.535850.Mueller C., Kallert S., Renner B. et al. Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 2003;41(1):2—6.Hummel T., Sekinger B., Wolf S.R. et al. ‘Sniffin’ sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997;22(1):39-52. DOI: 10.1093/chemse/22.1.39.Kobal G., Hummel T., Sekinger B et al. “Sniffin’ sticks”: screening of olfactory performance. Rhinology 1996;34(4):222—6.Fjaeldstad A., Kjaergaard T., Van Harte-velt T.J. et al. Olfactory screening: validation of Sniffin’ Sticks in Denmark. Clin Otolaryngol 2015;40(6):545-50. DOI: 10.1111/coa.12405.Ovesen L., Hannibal J., Sorensen M., Allingstrup L. Food intake, eating-related complaints, and smell and taste sensations in patients with cancer of the lung, ovary and breast undergoing chemotherapy. Clin Nutr 1991;10(6):336—41.Schiffman S.S., Sattely-Miller E.A., Taylor E.L. et al. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. J Nutr Health Aging 2007;11(5):439-54.Stevens J., Cain W., Burke R. Variability of olfactory thresholds. Chem Senses 1988;13(4):643-53.Heywood P.G., Costanzo R.M. Identifying normosmics: a comparison of two populations. Am J Otolaryngol 1986;7(3):194—9.Hoffman H.J., Cruickshanks K.J., Davis B. Perspectives on population-based epidemiological studies of olfactory and taste impairment. Ann N Y Acad Sci 2009;1170:514-30. DOI: 10.im/j.1749-6632.2009.04597.x.Doty R.L. Office procedures for quantitative assessment of olfactory function. Am J Rhinol 2007;21(4):460-73.Heald A.E., Pieper C.F., Schiffman S.S. Taste and smell complaints in HIV-infected patients. AIDS 1998;12(13):1667-74.Brisbois T.D., de Kock I.H., Wata-nabe S.M. et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, doubleblind, placebo-controlled pilot trial. Ann Oncol 2011;22(9):2086—93. DOI: 10.1093/annonc/mdq727.Mirlohi S., Duncan S.E., Harmon M. et al. Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors. Clin Oral Investig 2015;19(1):127—37. DOI: 10.1007/s00784-014-1211-8.McGreevy J., Orrevall Y., Belqaid K. et al. Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer. Support Care Cancer 2014;22(10):2635—44. DOI: 10.1007/s00520-014-2215-2.Heckel M., Stiel S., Ostgathe C. Smell and taste in palliative care: a systematic analysis of literature. Eur Arch Otorhinolaryngol 2015;272(2):279—88. DOI: 10.1007/s00405-014-3016-4.Newell S., Sanson-Fisher R.W., Girgis A., Bonaventura A. How well do medical oncologists’ perceptions reflect their patients’ reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 1998;83(8):1640—51.Zabernigg A., Gamper E.M., Giesinger J.M. et al. Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist 2010;15(8):913—20. DOI: 10.1634/theoncologist.2009-0333.Steinbach S., Hummel T., Bohner C. et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 2009;27(11):1899—905. DOI: 10.1200/JCO.2008.19.2690.Williams L.R., Cohen M.H. Altered taste thresholds in lung cancer. Am J Clin Nutr 1978;31(1):122—5. DOI: 10.1093/ajcn/31.1.122.Belqaid K., Tishelman C., McGreevy J. et al. A longitudinal study of changing characteristics of self-reported taste and smell alterations in patients treated for lung cancer. Eur J Oncol Nurs 2016;21:232—41. DOI: 10.1016/j.ejon.2015.10.009.Sarhill N., Mahmoud F., Walsh D. et al. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 2003;11(10):652—9. DOI: 10.1007/s00520-003-0486-0.Imai H., Soeda H., Komine K. et al. Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer. BMC Palliat Care 2013;12(1):38. DOI: 10.1186/1472-684X-12-38.Lehrer S., Levine E., Bloomer W.D. Abnormally diminished sense of smell in women with oestrogen receptor positive breast cancer. Lancet 1985;2(8450):333.Comeau T.B., Epstein J.B., Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 2001;9(8):575—80.Schiffman S.S. Taste and smell losses in normal aging and disease. JAMA 1997;278(16):1357—62.Bartoshuk L.M. Chemosensory alterations and cancer therapies. NCI Monogr 1990;(9):179—84.Gill S.S., Frew J., Fry A. et al. Priorities for the head and neck cancer patient, their companion and members of the multidisciplinary team and decision regret. Clin Oncol(R Coll Radiol) 2011;23(8):518—24. DOI: 10.1016/j.clon.2011.03.014.Melo Filho M.R., Rocha B.A., Pires M.B. et al. Quality of life of patients with head and neck cancer. Braz J Otorhinolaryngol 2013;79(1):82—8.Chencharick J.D., Mossman K.L. Nutritional consequences of the radiotherapy of head and neck cancer. Cancer 1983;51(5):811—5.Belqaid K., Orrevall Y., McGreevy J. et al. Self-reported taste and smell alterations in patients under investigation for lung cancer. Acta Oncol 2014;53(10):1405—12. DOI: 10.3109/0284186X.2014.895035.Spotten L., Corish C., Lorton C. et al. Subjective taste and smell changes in treatment-naive people with solid tumours. Support Care Cancer 2016;24(7):3201—8. DOI: 10.1007/s00520-016-3133-2.Duguet A., Bachmann P., Lallemand Y. Summary report of the Standards, options and recommendations for malnutrition and nutritional assessment in patients with cancer. Br J Cancer 2003;89 Suppl 1:S92—7. DOI: 10.1038/sj.bjc.6601089.Snegovoy A.V., Leyderman I.N., Saltanov A.I., Strelchuk V.Yu. Main principles and technologies of clinical nutrition in oncology. Guidelines for doctors. Moscow, 2006. (In Russ.).Снеговой А.В., Лейдерман И.Н., Салтанов А.И., Стрельчук В.Ю. Основные принципы и технологии клинического питания в онкологии. Методическое руководство для врачей. М., 2006.Kondrup J., Allison S.P., Elia M. et al. ESPEN Guidelines for nutrition screening 2002. Clin Nutr 2003;22(4):415—21.Snegovoy A.V., Besova N.S., Veselov A.V. et al. Practical guidelines for nutritional support of cancer patients. Zlokachest-vennye opukholi = Malignant Tumors 2016;(4, Spec Issue 2):434—50. (In Russ.). DOI: 10.18027/2224-5057-2016-4s2-434-450.Снеговой А.В., Бесова Н.С., Веселов А.В. и др. Практические рекомендации по нутритивной поддержке онкологических больных. Злокачественные опухоли 2016;(4, спецвып. 2):434—50. DOI: 10.18027/2224-5057-2016-4s2-434-450.Snegovoy A.V., Selchuk V.Yu., Saltanov A.I. Nutricomp ADN Brown Fibre in patients with stomach cancer and postoperative complications. Vestnik intensivnoy terapii = Intensive Care Herald 2003;(2):86—7. (In Russ.).Снеговой А.В., Сельчук В.Ю., Салтанов А.И. Нутрикомп АДН Браун Фай-бер у больных раком желудка с послеоперационными осложнениями. Вестник интенсивной терапии 2003; (2):86—7.Sanchez Alvarez C., Nunez Ruiz R., Moran Garcia V. [Nutritional support in the patient with GI malignancy (In Spanish)]. Nutr Hosp 2005;20(2):38—40.Luft V.M., Luft A.V. Nutritional support of cancer patients: possibilities and contradictions. Intensive care Bulletin 2008;(2):43—50. (In Russ.).Луфт В.М., Луфт А.В. Нутриционная поддержка онкологических больных: возможности и противоречия. Vestnik intensivnoy terapii = Intensive Care Herald 2008;(2):43—50.Bozzetti F., Bozzetti V. Efficacy of enteral and parenteral nutrition in cancer patients. Nestle Nutr Workshop Ser Clin Perform Programme 2005;10:127—39. DOI: 10.1159/000083302.Snegovoy A.V., Saltanov A.I., Manzuk L.V. et al. Evaluation of the efficiency of the nutrition support with Forticare enteral mixture at patients with oncologic diseases during the radial and chemical therapy. Vestnik intensivnoy terapii = Intensive Therapy Herald 2009;(4):77—83. (In Russ.).Снеговой А.В., Салтанов А.И., Манзюк Л.В. и др. Оценка эффективности нутритивной поддержки энтеральной смесью «Фортикер» у пациентов с онкологическими заболеваниями в период лучевой и химиотерапии. Вестник интенсивной терапии 2009;(4):77—83.Elia M., Van Bokhorst-de van der Schue-ren M.A., Garvey J. et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 2006;28(1):5—23. DOI: 10.3892/ijo.28.1.5.Epstein J.B., Phillips N., Parry J. et al. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002;30(11):785—92. DOI: 10.1038/sj.bmt.1703716.Pfister S., Dietrich M.G., Sidler C. et al. Characterization and turnover of CD73/ IP(3)R3-positive microvillar cells in the adult mouse olfactory epithelium. Chem Senses 2012;37(9):859—68. DOI: 10.1093/chemse/bjs069.Bernhardson B.M., Tishelman C., Rutqvist L.E. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage 2007;34(4):403—12. DOI: 10.1016/j.jpainsymman.2006.12.010.Steinbach S., Hundt W., Schmalfeldt B. et al. Effect of platinum-containing chemotherapy on olfactory, gustatory, and hearing function in ovarian cancer patients. Arch Gynecol Obstet 2012;286(2):473—80. DOI: 10.1007/s00404-012-2307-5.Nishijima S., Yanase T., Tsuneki I. et al. Examination of the taste disorder associated with gynecological cancer chemotherapy. Gynecol Oncol 2013;131(3):674—8. DOI: 10.1016/j.ygyno.2013.09.015.Wickham R.S., Rehwaldt M., Kefer C. et al. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 1999;26(4):697—706.Boltong A., Aranda S., Keast R. et al. A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes. PLoS One 2014;9(7):e103512. DOI: 10.1371/journal.pone.0103512.Riga M., Chelis L., Papazi T. et al. Hyposmia: an underestimated and frequent adverse effect of chemotherapy. Support Care Cancer 2015;23(10):3053—8. DOI: 10.1007/s00520-015-2675-z.Holscher T., Seibt A., Appold S. et al. Effects of radiotherapy on olfactory function. Radiother Oncol 2005;77(2):157—63. DOI: 10.1016/j.radonc.2005.09.015.Yamashita H., Nakagawa K., Tago M. et al. Taste dysfunction in patients receiving radiotherapy. Head Neck 2006;28(6):508—16. DOI: 10.1002/hed.20347Leyrer C.M., Chan M.D., Peiffer A.M. et al. Taste and smell disturbances after brain irradiation: a dose-volume histogram analysis of a prospective observational study. Pract Radiat Oncol 2014;4(2):130—5. DOI: 10.1016/j.prro.2013.06.003.Ovesen L., Hannibal J., Snrensen M. Taste thresholds in patients with small-cell lung cancer. J Cancer Res Clin Oncol 1991;117(1):70—2.Sandow P.L., Hejrat-Yazdi M., Heft M.W. Taste loss and recovery following radiation therapy. J Dent Res 2006;85(7):608—11. DOI: 10.1177/154405910608500705.Ripamonti C., Zecca E., Brunelli C. et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 1998;82(10):1938—45.Lin A., Kim H.M., Terrell J.E. et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57(1):61—70.Doty R.L., Tourbier I., Ng V. et al. Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women. Neurobiol Aging 2015;36(6):2053—9. DOI: 10.1016/j.neurobiolaging.2015.02.028.Ros C., Alobid I., Centellas S. et al. Loss of smell but not taste in adult women with Turner’s syndrome and other congenital hypogonadisms. Maturitas 2012;73(3):244—50. DOI: 10.1016/j.maturitas.2012.07.012.Mattes R., Arnold C., Boraas M. Learned food aversion among cancer chemotherapy patients. Incidence, nature, and clinical implications. Cancer 1987;60(10):2576—80.Bosaeus I., Daneryd P., Svanberg E., Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 2001;93(3):380—3.Holmes S. Food avoidance in patients undergoing cancer chemotherapy. Support Care Cancer 1993;1(6):326—30.Cunningham R.S., Bell R. Nutrition in cancer: an overview. Semin Oncol Nurs 2000;16(2):90—8.Vigano A., Bruera E., Jhangri G.S. et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000;160(6):861 —8.Aapro M., Arends J., Bozzetti F. et al. Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol 2014;25(8):1492—9. DOI: 10.1093/annonc/mdu085.Arends J., Bodoky G., Bozzetti F. et al. ESPEN Guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 2006;25(2):245—59. DOI: 10.1016/j.clnu.2006.01.020.Andreyev H.J., Norman A.R., Oates J., Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998;34(4):503—9.Hill A., Kiss N., Hodgson B. et al. Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr 2011;30(1):92—8. DOI: 10.1016/j.clnu.2010.07.015.Jagoe R.T., Goodship T.H., Gibson G.J. The influence of nutritional status on complications after operations for lung cancer. Ann Thorac Surg 2001;71(3):936—43.Baharvand M., Shoaleh Saadi N., Barakian R., Moghaddam E.J. Taste alteration and impact on quality of life after head and neck radiotherapy. J Oral Pathol Med 2013;42(1):106—12. DOI: 10.1111/j.1600-0714.2012.01200.x.Johannesen T.B., Rasmussen K., Winther F.0. et al. Late radiation effects on hearing, vestibular function, and taste in brain tumor patients. Int J Radiat Oncol Biol Phys 2002;53(1):86—90.Cohen J., Laing D.G., Wilkes F.J. et al. Taste and smell dysfunction in childhood cancer survivors. Appetite 2014;75:135-40. DOI: 10.1016/j.appet.2014.01.001.Janssens G.O., Langendijk J.A., Terhaard C.H. et al. Quality-of-life after radiotherapy for advanced laryngeal cancer: results of a phase III trial of the Dutch Head and Neck Society. Radiother Oncol 2016;119(2):213-20. DOI: 10.1016/j.radonc.2016.02.023.DeWys W.D., Walters K. Abnormalities of taste sensation in cancer patients. Cancer 1975;36(5):1888-96.McLaughlin L. Taste dysfunction in head and neck cancer survivors. Oncol Nurs Forum 2013;40(1):E4-13. DOI: 10.1188/13.ONF.E4-E13.Maes A., Huygh I., Weltens C. et al. De Gustibus: time scale of loss and recovery of tastes caused by radiotherapy. Radiother Oncol 2002;63(2):195—201.Kershaw J.C., Mattes R.D. Nutrition and taste and smell dysfunction. World J Otorhinolaryngol Head Neck Surgery 2018;4(1):3—10. DOI: 10.1016/j.wjorl.2018.02.006.De Haan J.J., Moshage Y., Kluifhooft D. et al. Impact of taste alterations during systemic anti-tumour therapy on the liking of oral nutritional supplements with adapted flavours. Ann Oncol 2018;29(suppl 8):viii603—40.